Cardiac Resynchronization Therapy Devices

Types of artificial pacemakers with implantable leads to be placed at multiple intracardial sites. They are used to treat various cardiac conduction disturbances which interfere with the timing of contraction of the ventricles. They may or may not include defibrillating electrodes (IMPLANTABLE DEFIBRILLATORS) as well.

Also Known As:

Networked: 108 relevant articles (6 outcomes, 13 trials/studies)

Relationship Network

Therapy Context: Research Results

Experts

1.	Singh, Jagmeet P: 4 articles (06/2021 - 10/2007)
2.	Mitsuhashi, Takeshi: 3 articles (11/2017 - 04/2015)
3.	Nitta, Takashi: 3 articles (11/2017 - 04/2015)
4.	Okumura, Ken: 3 articles (11/2017 - 04/2015)
5.	Shimizu, Akihiko: 3 articles (11/2017 - 04/2015)
6.	Yamagata, Kenichiro: 2 articles (01/2022 - 01/2020)
7.	Bera, Debabrata: 2 articles (10/2020 - 05/2018)
8.	Al-Khatib, Sana M: 2 articles (02/2019 - 12/2013)
9.	Russo, Andrea M: 2 articles (01/2019 - 12/2013)
10.	Furushima, Hiroshi: 2 articles (11/2017 - 12/2016)

Related Diseases

1.	Atrial Fibrillation 03/01/2013 - "A meta-analysis of patients with atrial fibrillation and symptomatic HF who had implanted cardiac resynchronization therapy devices and performed atrioventricular node ablation showed significant reduction in all-cause and cardiovascular mortality, and improvement in HF functional class. " 01/01/2008 - "Cardiac resynchronization therapy devices are likely to be beneficial in select patients with chronic atrial fibrillation." 10/04/2014 - "Pilot-CRAfT is the first randomized controlled trial evaluating the efficacy of a rhythm control strategy in atrial fibrillation patients with cardiac resynchronization therapy devices. " 08/01/2018 - "Assessment of DNA Damage After Ionizing Radiation Exposure in Patients Undergoing Cardiac Resynchronization Therapy Device Implantation or Atrial Fibrillation Ablation (The RADAR Study)." 09/01/2008 - "Atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trial."
2.	Heart Failure 06/01/2010 - "The most recent MADIT-CRT trial showed that a cardiac resynchronization therapy device with defibrillator (CRT-D) was effective in reducing the risk of heart failure or death, whichever came first, in cardiac patients who were asymptomatic or minimally symptomatic (New York Heart Association class I or II) with reduced ejection fraction < or =0.30 and wide QRS complex > or =130 ms when compared with an implantable cardiac defibrillator (ICD) device. " 04/01/2017 - "Randomized controlled trials demonstrate that remote monitoring (RM) of implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy devices (CRT-Ds) may improve quality of care and prognosis in heart failure (HF) patients. " 12/18/2012 - "Sprint Fidelis lead fractures in patients with cardiac resynchronization therapy devices: insight from the Resynchronization/Defibrillation for Ambulatory Heart Failure (RAFT) study." 08/01/2012 - "The aim of this study was to assess the performance of the SHFM when applied to patients with heart failure who received cardiac resynchronization therapy devices with defibrillation. " 08/01/2006 - "Over the last few years, significant advances in cardiac resynchronization therapy technology and the publication of large-scale clinical trials using cardiac resynchronization therapy devices in patients with heart failure have led to the widespread use of these devices. "
3.	Heart Diseases (Heart Disease) 12/01/2019 - "In conclusion, cardiac resynchronization therapy device therapy is both feasible and effective in treating advanced cardiac disease in this vulnerable group of patients by improving left ventricular function." 10/26/2017 - "It is possible to identify three main fields of application of CMR in this context: (1) arrhythmic and sudden cardiac death risk stratification in different heart diseases; (2) decision-making in cardiac resynchronization therapy device implantation, presence and extent of myocardial fibrosis for left ventricular lead placement and cardiac venous anatomy; and (3) substrate identification for guiding ablation of complex arrhythmias (atrial fibrillation and ventricular tachycardias)."
4.	Sarcoidosis (Schaumann Disease) 12/15/2019 - "Treatment involving the insertion of an implantable cardioverter defibrillator and cardiac resynchronization therapy devices has markedly improved the prognosis of cardiac sarcoidosis. "
5.	Ventricular Tachycardia 01/01/2021 - "We used standard 12-lead ECGs and up to 224 unipolar body-surface ECGs to record three patients with cardiac resynchronization therapy devices and three patients with focal ventricular tachycardia. " 11/24/2017 - "Randomized control trials comparing the effectiveness of cardiac resynchronization therapy devices, with (CRT-D) or without (CRT-P) a defibrillator, are scarce in heart failure patients with no prior sustained ventricular tachyarrhythmias.Methods and Results:The Japan Cardiac Device Treatment Registry (JCDTR) has data for 2714 CRT-D and 555 CRT-P recipients for primary prevention with an implantation date between January 2011 and August 2015. " 01/01/2016 - "We aimed to determine the association between the LV lead pacing polarity for heart failure (HF) or death and ventricular tachyarrhythmias (VTA) in patients enrolled in MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy), receiving a cardiac resynchronization therapy device with implanted cardioverter-defibrillator (CRT-D). " 01/01/2018 - "To evaluate the impact of different right and left ventricular lead positions (RV-LP and LV-LP) on the risk of therapy for ventricular tachycardia/ventricular fibrillation in patients with a cardiac resynchronization therapy device (CRT-D). " 09/01/2015 - "Clinical scenarios were described focusing on four key areas: the implantation of pacemakers for bradyarrhythmia detected on an implantable loop recorder (ILR), the management of patients with ventricular arrhythmia detected by an ILR or pacemaker, the management of atrial fibrillation in patients with pacemakers and cardiac resynchronization therapy devices and the management of ventricular tachycardia in patients with implantable cardioverter-defibrillators. "

Related Drugs and Biologics

1.	C-Reactive Protein

Related Therapies and Procedures

1.	Defibrillators (Defibrillator)
2.	Implantable Defibrillators (Implantable Cardioverter-Defibrillator)
3.	Therapeutics
4.	Cardiac Resynchronization Therapy
5.	Percutaneous Coronary Intervention